DCGI allows Serum Institute to export Ebola vaccine to Uganda

The approval for export comes after an application was submitted to the Drugs Controller General of India by Prakash Kumar Singh, Director, Serum Institute of India, on November 30.

Published On 2022-12-09 06:45 GMT | Update On 2024-02-13 21:23 GMT

New Delhi: India's first Ebola vaccine manufactured by Serum Institute has been approved by the Drugs Controller General of India (DCGI) for export to Uganda, official sources said Thursday. The vaccine has been developed by Serum Institute in collaboration with Oxford University, UK. According to sources, this vaccine will be used for solidarity clinical trials in Uganda.WHO had...

New Delhi: India's first Ebola vaccine manufactured by Serum Institute has been approved by the Drugs Controller General of India (DCGI) for export to Uganda, official sources said Thursday.

The vaccine has been developed by Serum Institute in collaboration with Oxford University, UK. According to sources, this vaccine will be used for solidarity clinical trials in Uganda.

WHO had sought collaboration with manufacturers of ebola vaccines for the prevention of the disease and has selected ChAdOx1 biEBOV as a potential vaccine for participation in a solidarity clinical trial in Uganda.

Oxford University signed an agreement with Serum Institute of India to manufacture ChAdOx1 biEBOV.

The approval for export comes after an application was submitted to the Drugs Controller General of India by Prakash Kumar Singh, Director, Serum Institute of India, on November 30.

"We, Serum Institute of India, under the visionary leadership of our CEO Dr Adar C Poonawalla, are committed to making available various world-class life-saving vaccines to our country and the world at large in the line with the clarion call of Prime Minister Narendra Modi 'Making in India for the World," the official source quoted Singh as having said in the application.

Ebola virus disease (EVD), formerly known as Ebola haemorrhagic fever, is a rare but severe, often fatal illness in humans. The virus is transmitted to people from wild animals and spreads in the human population through human-to-human transmission. The virus family Filoviridae includes three genera: Cuevavirus, Marburgvirus, and Ebolavirus. Within the genus Ebolavirus, six species have been identified: Zaire, Bundibugyo, Sudan, Taï Forest, Reston and Bombali.

Serum Institute of India is an Indian biotechnology and biopharmaceuticals company headquartered in Pune, India. The company was founded by Dr. Cyrus Poonawalla in 1966.

Article Source : with inputs

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Desk Editor for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

DCGI allows Serum Institute to export Ebola vaccine to Uganda

The approval for export comes after an application was submitted to the Drugs Controller General of India by Prakash Kumar Singh, Director, Serum Institute of India, on November 30.

Similar News